• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Paxlovid and long COVID; hearing loss and dementia risk; $93M in health care fraud - Morning Medical Update


The top news stories in primary care today.

Doctor morning desk: © Alena Kryazheva –

Doctor morning desk: © Alena Kryazheva –

Paxlovid vs. long COVID

Long COVID occurs in about 10% of patients with COVID-19 globally and could affect up to 65 million people worldwide. Researchers found patients treated with nirmatrelvir-ritonavir (Paxlovid) did not show a lower prevalence of long COVID symptoms 90 days after infection.

Hearing against dementia

Even mild hearing loss is associated with an increased risk of dementia. But a new study involving more than 573,000 participants in Denmark suggests hearing aids may reduce risk of dementia.

$93M in medical fraud

A federal judge handed down sentences for a home health therapy and money laundering fraud scheme that billed Medicare $93 million for services never provided, according to the U.S. Department of Justice. A 42-year-old man was sentenced to eight years and four months in prison, while a 54-year-old woman co-conspirator was sentenced to five years and 10 months in prison. They were convicted at a jury trial of using stolen patient identities and individuals in Cuba in the scheme.

Related Videos